Skip to content

Clinical Comparative Trial of a Modified Polyurethane Dressing and Aquacel

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01055925
Enrollment
Unknown
Registered
2010-01-26
Start date
Unknown
Completion date
Unknown
Last updated
2010-01-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Reepithelialization of Skin Graft Donor Sites

Brief summary

The almost single disadvantage of conventional polyurethane film dressings, an uncontrolled leakage, is probably as often described as its numerous advantages for split-thickness skin graft (STSG) donor sites. This shortcoming can be overcome by perforating the polyurethane dressing (MPD), which permits a controlled leakage into a secondary absorbent dressing. The study was conducted to compare the MPD-system and Aquacel® (ConvaTec), a hydrofiber wound dressing, which also seems to fulfill all criteria of an ideal donor site dressing.

Interventions

DEVICEmodified polyurethane film dressing (OpSite, Smith&Nephew, London, UK)
DEVICEAquacel® (ConvaTec, Skillman, NJ, USA), sodium carboxy-methylcellulose hydrocolloid polymer dressing

Sponsors

Klinik Bogenhausen
Lead SponsorOTHER

Study design

Primary purpose
TREATMENT

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* skin graft donor site anterolateral thigh * men and women \> 18 years

Exclusion criteria

* informed consent missing * repeated skin graft take or prior injury at the observed site * Subject unlikely to comply with protocol, e.g., uncooperative attitude, inability to return for follow-up visits, and unlikelihood of completing the study * History of hypersensitivity to the investigational products

Design outcomes

Primary

MeasureTime frame
reepithelialization rate10th day postoperative

Secondary

MeasureTime frame
pain, scar formation, complications (e.g. infection), costspain until and during dressing removal, scar formation 60 days following surgery

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026